Status | Study |
Available |
Study Name: Treatment Use of 3,4-Diaminopyridine Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Myasthenic Syndromes, Congenital Date: 2013-01-06 Interventions: Drug: 3,4-diaminopyridine Trea |
Available |
Study Name: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome Condition: Lambert-Eaton Myasthenic Syndrome Eaton-Lambert Myasthenic Syndrome Date: 2011-12-24 Interventions: Drug: 3,4-DAP Subjects will ma |
Terminated |
Study Name: IVIG Treatment for Refractory Immune-Related Adult Epilepsy Condition: Epilepsy, Cryptogenic Epilepsy, Partial Seizure Disorder Date: 2011-11-30 Interventions: Drug: IVIG IVIG 2 mg/kg in two divided doses with placebo crossover |
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |
No longer available |
Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2011-06-20 Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |
Completed |
Study Name: A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS) Condition: Lambert Eaton Myasthenic Syndrome Date: 2011-06-17 Interventions: Drug: Amifampridine Phosphate |
No longer available |
Study Name: Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome Condition: Lambert-Eaton Myasthenic Syndrome Date: 2011-06-13 Interventions: Drug: 3,4 DAP Recommended maximum dosage: 20mg four times daily and if needed an additional 20 mg per da |
Completed |
Study Name: MC-5A for Chemotherapy Induced Peripheral Neuropathy Condition: Neuropathy, Paraneoplastic Date: 2010-12-09 Interventions: Device: MC-5A 45 minutes daily |
Completed |
Study Name: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes Condition: Congenital Myasthenic Syndrome Date: 2010-09-15 Interventions: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or |
Available |
Study Name: Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine Condition: Lambert-Eaton Myasthenic Syndrome Date: 2009-10-08 Interventions: Drug: 3,4 diaminopyridine 3,4 diaminopyridine up to 80 mg daily in divided doses |